Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
Souza, Thiago Moreno L., Pinho, Vagner D., Setim, Cristina F., Sacramento, Carolina Q., Marcon, Rodrigo, Fintelman-Rodrigues, Natalia, Chaves, Otavio A., Heller, Melina, Temerozo, Jairo R., Ferreira, André C., Mattos, Mayara, Momo, Patrícia B., Dias, Suelen S. G., Gesto, João S. M., Pereira-Dutra, Filipe, Viola, João P. B., Queiroz-Junior, Celso Martins, Guimarães, Lays Cordeiro, Chaves, Ian Meira, Guimarães, Pedro Pires Goulart, Costa, Vivian Vasconcelos, Teixeira, Mauro Martins, Bou-Habib, Dumith Chequer, Bozza, Patrícia T., Aguillón, Anderson R., Siqueira-Junior, Jarbas, Macedo-Junior, Sergio, Andrade, Edineia L., Fadanni, Guilherme P., Tolouei, Sara E. L., Potrich, Francine B., Santos, Adara A., Marques, Naiani F., Calixto, João B., Rabi, Jaime A.
Published in Nature communications (13.01.2023)
Published in Nature communications (13.01.2023)
Get full text
Journal Article